VHA to take Surgical Dynamics' spine products:
This article was originally published in Clinica
Executive Summary
Surgical Dynamics, the subsidiary of United States Surgical, has signed a three-year deal with US healthcare provider VHA for all its spine and arthroscopic products. The deal includes the Ray Threaded Fusion Cage designed to treat low back pain by restoring disc space while the patient's own bone grows though the device to fuse the vertebrae. Sofamor Danek has lost its patent dispute with Surgical Dynamics over the Ray TFC, according to Reuters.
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.